237 related articles for article (PubMed ID: 12082608)
21. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M
Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653
[TBL] [Abstract][Full Text] [Related]
22. Time- and oxygen-dependent expression and regulation of NDRG1 in human brain cancer cells.
Said HM; Safari R; Al-Kafaji G; Ernestus RI; Löhr M; Katzer A; Flentje M; Hagemann C
Oncol Rep; 2017 Jun; 37(6):3625-3634. PubMed ID: 28498432
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia Drives Breast Tumor Malignancy through a TET-TNFα-p38-MAPK Signaling Axis.
Wu MZ; Chen SF; Nieh S; Benner C; Ger LP; Jan CI; Ma L; Chen CH; Hishida T; Chang HT; Lin YS; Montserrat N; Gascon P; Sancho-Martinez I; Izpisua Belmonte JC
Cancer Res; 2015 Sep; 75(18):3912-24. PubMed ID: 26294212
[TBL] [Abstract][Full Text] [Related]
24. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.
Kim CK; Nguyen TL; Joo KM; Nam DH; Park J; Lee KH; Cho SW; Ahn JY
Cancer Res; 2010 Dec; 70(23):9730-41. PubMed ID: 21098709
[TBL] [Abstract][Full Text] [Related]
25. Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem-Like Cell Fate in an Oxygen-Dependent Manner.
Soubéran A; Cappaï J; Chocry M; Nuccio C; Raujol J; Colin C; Lafitte D; Kovacic H; Quillien V; Baeza-Kallee N; Rougon G; Figarella-Branger D; Tchoghandjian A
Stem Cells; 2019 Jun; 37(6):731-742. PubMed ID: 30920104
[TBL] [Abstract][Full Text] [Related]
26. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
27. NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme.
Hsieh CH; Shyu WC; Chiang CY; Kuo JW; Shen WC; Liu RS
PLoS One; 2011; 6(9):e23945. PubMed ID: 21935366
[TBL] [Abstract][Full Text] [Related]
28. The role of p53 in hypoxia-induced apoptosis.
Hammond EM; Giaccia AJ
Biochem Biophys Res Commun; 2005 Jun; 331(3):718-25. PubMed ID: 15865928
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.
Huang J; Chen K; Huang J; Gong W; Dunlop NM; Howard OM; Bian X; Gao Y; Wang JM
Carcinogenesis; 2009 Feb; 30(2):348-55. PubMed ID: 19037090
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells.
Mughal AA; Grieg Z; Skjellegrind H; Fayzullin A; Lamkhannat M; Joel M; Ahmed MS; Murrell W; Vik-Mo EO; Langmoen IA; Stangeland B
Mol Cancer; 2015 Aug; 14():160. PubMed ID: 26292663
[TBL] [Abstract][Full Text] [Related]
31. HIF-1 and p53: communication of transcription factors under hypoxia.
Schmid T; Zhou J; Brüne B
J Cell Mol Med; 2004; 8(4):423-31. PubMed ID: 15601571
[TBL] [Abstract][Full Text] [Related]
32. HIF-1alpha and p53 promote hypoxia-induced delayed neuronal death in models of CNS ischemia.
Halterman MW; Federoff HJ
Exp Neurol; 1999 Sep; 159(1):65-72. PubMed ID: 10486175
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo.
Köck H; Harris MP; Anderson SC; Machemer T; Hancock W; Sutjipto S; Wills KN; Gregory RJ; Shepard HM; Westphal M; Maneval DC
Int J Cancer; 1996 Sep; 67(6):808-15. PubMed ID: 8824552
[TBL] [Abstract][Full Text] [Related]
34. Oct-3/4 promotes tumor angiogenesis through VEGF production in glioblastoma.
Takahashi H; Inoue A; Kawabe Y; Hosokawa Y; Iwata S; Sugimoto K; Yano H; Yamashita D; Harada H; Kohno S; Ohue S; Ohnishi T; Tanaka J
Brain Tumor Pathol; 2015 Jan; 32(1):31-40. PubMed ID: 25348671
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis inhibitor as a suppressor of tumor progression: expression of Bcl-2 eliminates selective advantages for p53-deficient cells in the tumor.
Gurova KV; Kwek SS; Koman IE; Komarov AP; Kandel E; Nikiforov MA; Gudkov AV
Cancer Biol Ther; 2002; 1(1):39-44. PubMed ID: 12170763
[TBL] [Abstract][Full Text] [Related]
36. Targeting gene expression to hypoxic tumor cells.
Dachs GU; Patterson AV; Firth JD; Ratcliffe PJ; Townsend KM; Stratford IJ; Harris AL
Nat Med; 1997 May; 3(5):515-20. PubMed ID: 9142119
[TBL] [Abstract][Full Text] [Related]
37. Microarray analysis of p53-dependent gene expression in response to hypoxia and DNA damage.
Corn PG; El-Deiry WS
Cancer Biol Ther; 2007 Dec; 6(12):1858-66. PubMed ID: 18087215
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression.
Semenza GL
Crit Rev Biochem Mol Biol; 2000; 35(2):71-103. PubMed ID: 10821478
[TBL] [Abstract][Full Text] [Related]
39. In regard to DAI et al.: inhibition of hypoxia inducible factor 1alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells. IJROBP 2003;55:1027-1036).
Vordermark D
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1196. PubMed ID: 14575853
[No Abstract] [Full Text] [Related]
40. Cyclophilin B supports Myc and mutant p53-dependent survival of glioblastoma multiforme cells.
Choi JW; Schroeder MA; Sarkaria JN; Bram RJ
Cancer Res; 2014 Jan; 74(2):484-96. PubMed ID: 24272483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
